AM-855
From Wikipedia, the free encyclopedia
AM-855
|
|
Systematic (IUPAC) name | |
(4aR,12bR)-8-hexyl-2,5,5-trimethyl-1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C26H38O2 |
Mol. mass | 382.577 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
AM-855 is an analgesic drug which is a cannabinoid agonist. It is a derivative of Δ8THC with a conformationally restricted side chain which has been bound into a fourth ring fused to the aromatic A-ring of the cannabinoid skeleton. AM-855 is an agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 22.3nM at CB1 and 58.6nM at CB2.[1]
[edit] References
- ^ Khanolkar AD, Lu D, Fan P, Tian X, Makriyannis A. Novel conformationally restricted tetracyclic analogs of delta8-tetrahydrocannabinol. Bioorganic and Medicinal Chemistry Letters. 1999 Aug 2;9(15):2119-24. PMID 10465529
|